Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele
Dominique Grouselle(Inserm), Jacques Epelbaum(Centre National de la Recherche Scientifique), Raphaëlle Winsky‐Sommerer(Inserm), Pascal Dournaud(Délégation Paris 7), Jean Philippe David(Centre hospitalier Emile Roux), André Delacourte(Inserm)
Cited by 92
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
|Molecular Psychiatry|2013|440
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The role of JAK-STAT signaling within the CNS
|JAK-STAT|2013|352